
|Articles|October 30, 2015
Drug Pricing Controversy Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/drug-pricing-controversy-highlights-specialty-phar" target="_blank">View the story "Drug Pricing Controversy Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
2
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
3
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
4
FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer
5














































































































































































































